The DOI matches its Crossref record.
Expression of polo‐like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease
Abstract
Background: The maximum thickness of a primary malignant melanoma as measured by Breslow's method is currently the most important prognostic factor. However, some thin melanomas (≤ 0.75 mm), which should have an excellent prognosis according to Breslow, can be lethal due to their ability to metastasize. Methods: In our study, thin malignant melanomas (≤ 0.75 mm) from 36 patients were analyzed with immunohistochemical techniques using monoclonal antibodies directed against PLK1 and Ki‐67. The immunoreactivity of 22 melanomas which developed metastases within 5 years of follow‐up was compared with a group of 14 non‐metastasized melanomas. Two independent investigators evaluated stained sections. Differences of PLK1 and Ki‐67 indices between melanomas with and without metastases were tested statistically using the Mann–Whitney U‐test. Results: Malignant melanomas with metastases expressed PLK1 at markedly elevated levels compared to melanomas without metastases (median, 60.00% vs. 37.98%; p = 0.000053). The difference of the Ki‐67 index between both groups was not significant (median, 6.35% vs. 4.53%; p = 0.150473). Conclusions: Our results suggest that PLK1 expression in thin melanomas is a reliable marker to identify patients at high risk for metastases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Targeting polo-like kinase 1 for cancer therapy
Strebhardt, K., & Ullrich, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1841 · Cited by 841
Self-citationPLK1, A Potential Target for Cancer Therapy
Liu, Z., Sun, Q., & Wang, X. (2017) · Translational Oncology · doi:10.1016/j.tranon.2016.10.003 · Cited by 454
Polo-like kinases (Plks) and cancer
Takai, N., Hamanaka, R., Yoshimatsu, J., & Miyakawa, I. (2005) · Oncogene · doi:10.1038/sj.onc.1208272 · Cited by 386
Polo‐like kinase 1 (PLK1) is overexpressed in primary colorectal cancers
Takahashi, T., Sano, B., Nagata, T., Kato, H., Sugiyama, Y., Kunieda, K., Kimura, M., Okano, Y., & Saji, S. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01411.x · Cited by 265
Targeting Polo-like Kinase in Cancer Therapy
Degenhardt, Y., & Lampkin, T. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1380 · Cited by 262
Metadata
- Authors
- Kneisel, L., Strebhardt, K., Bernd, A., Wolter, M., Binder, A., & Kaufmann, R.
- Venue
- Journal of Cutaneous Pathology
- Publisher
- Wiley
- Published
- 2002-07
- Volume
- 29
- Issue
- 6
- Pages
- 354-358
- ISSN
- 0303-6987 (ISSN-L)
- 1600-0560
- OpenAlex
- W2082087067
- Cited by
- 158
- References
- 0
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression of polo‐like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease. https://app.cochat.ai/papers/10.1034/j.1600-0560.2002.290605.x
- The paper
- Kneisel, L., Strebhardt, K., Bernd, A., Wolter, M., Binder, A., & Kaufmann, R. (2002). Expression of polo‐like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease. Journal of Cutaneous Pathology. https://doi.org/10.1034/j.1600-0560.2002.290605.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.